drugset / Trial / NCT00619697
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the efficacy on blood glucose control in type 2 diabetes.
Timeline
- Start
- 2003-12
- Primary completion
- 2005-03
- Completion
- 2005-03
Outcome
Met primary endpoint
paper between-group difference: -0.5% (95% CI: -0.8; -0.2); P=0.0002 PMID 17115351 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | — | — |
| Subject | Metformin | Small molecule | — | — |
| Subject | biphasic insulin aspart | Protein / enzyme biologic | 0.4 iu/kg | — |
| Subject | insulin glargine | Protein / enzyme biologic | 0.39 iu/kg | — |